KHIRON LIFE SCIENCES CORP. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.04 CAD | -.--% |
|
-.--% | -.--% |
Presenter SpeechChris Naprawa (Executives)Good morning, everybody. It's Chris Naprawa here, Pr...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 6.83M | |
| +42.38% | 6.26B | |
| -15.86% | 4.49B | |
| +6.36% | 3.29B | |
| -11.28% | 3.12B | |
| -3.23% | 2.5B | |
| +45.24% | 1.94B | |
| -7.89% | 1.68B | |
| -0.98% | 1.63B | |
| -11.32% | 1.56B |
- Stock Market
- Equities
- KHRN.H Stock
- News Khiron Life Sciences Corp.
- Transcript : Khiron Life Sciences Corp., Q1 2020 Earnings Call, May 29, 2020
